Image

Selection of Surgical Technique in Rectal Cancer

Selection of Surgical Technique in Rectal Cancer

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Currently, there is no prediction scale available to identify patients with rectal neoplasms as technically complex in the middle and lower thirds; that is, those who are at high risk of affected circumferential margins and low quality of the mesorectum. The application of a predictive model that allows preoperative identification of the group of patients in whom optimal results in mesorectal quality and circumferential margin are less likely to be obtained through laparoscopic or minimally invasive surgery would enable the selection of patients who will require and justify all efforts and healthcare resources to improve surgical outcomes.

Therefore, the investigators aim to create a predictive model to identify these patients, allowing the discrimination of which patients will benefit from different techniques, or even which ones would be opportune to initially consider an open approach.

Eligibility

Inclusion Criteria:

  • Scheduled surgery for anterior resection of the rectum meeting oncological criteria with mesorectal excision.
  • Age ≥ 18 years.
  • Histology of adenocarcinoma with or without neoadjuvant chemotherapy or chemoradiotherapy.
  • Initial stage T1-T4a. Any N. Any M.
  • Intention for R0 resection.

Exclusion Criteria:

  • Colorectal tumor with histology different from adenocarcinoma.
  • Synchronous colon tumor.
  • Benign pathology or adenoma.
  • Tis.
  • T4b or oncological multivisceral resections.
  • History of neoplastic colorectal surgery or local excision or TAMIS.
  • Perforated or obstructive rectal neoplasm.

Study details
    Rectal Neoplasms

NCT06442215

Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta

8 June 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.